ANDA 71481, held by Watson Labs. Ethinyl Estradiol; Norethindrone.
As of Nov 16, 2026, ANDA 71481 (Norethin 1/35e-28), held by Watson Labs, was first approved by FDA on Apr 12, 1988, with 14 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 12, 1988 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Norethin 1/35e-280.035MG;1MG · tablet;oral-28 | Ethinyl Estradiol; Norethindrone | Discontinued |
| Apr 29, 2022 | Supplement 16Labeling · Standard review | Approved | None posted |
| Feb 24, 2022 | Supplement 15Labeling · Standard review | Approved | None posted |
| Jul 11, 1997 | Supplement 14Labeling | Approved | None posted |
| Jan 13, 1997 | Supplement 13Manufacturing | Approved | None posted |
| Jan 13, 1997 | Supplement 12Manufacturing | Approved | None posted |
| Dec 23, 1993 | Supplement 11Manufacturing | Approved | None posted |
| Aug 28, 1992 | Supplement 9Labeling | Approved | None posted |
| May 1, 1992 | Supplement 10Labeling | Approved | None posted |
| Oct 11, 1991 | Supplement 8Labeling | Approved | None posted |
| Oct 11, 1991 | Supplement 7Labeling | Approved | None posted |
| Sep 9, 1991 | Supplement 6Manufacturing | Approved | None posted |
| Jun 19, 1991 | Supplement 4Manufacturing | Approved | None posted |
| May 24, 1991 | Supplement 5Labeling | Approved | None posted |
| Mar 22, 1991 | Supplement 2Manufacturing | Approved | None posted |
| Apr 12, 1988 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters